Spots Global Cancer Trial Database for CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer
Official Title: CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer
Study ID: NCT02764606
Conditions
Interventions
Study Description
Brief Summary: CANPOS is a non-interventional study aiming at evaluate at the time of initial surgery the value of new serum markers to predict the occurrence of metastases in patients with early-stage non-small cell lung cancer. This would represent a rational to develop personalized follow-up and prevention strategies
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hospices Civils de Lyon / Hôpital Neurologique Pierre Wertheimer, Bron, , France
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
